K Ulrich Ulli Bayer - Publications

Affiliations: 
UCHSC, Aurora, CO, United States 
Area:
Synaptic plasticity, Down syndrome, Schizophrenia, Addiction, Stroke, Global cerebral ischemia
Website:
http://www.ucdenver.edu/academics/colleges/medicalschool/departments/Pharmacology/faculty/Pages/bayer.aspx

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Barcomb K, Hell JW, Benke TA, Bayer KU. The CaMKII/GluN2B interaction maintains synaptic strength. The Journal of Biological Chemistry. PMID 27246855 DOI: 10.1074/jbc.M116.734822  1
2015 Barcomb K, Goodell DJ, Arnold DB, Bayer KU. Live imaging of endogenous CaMKII in neurons reveals that ischemia-related aggregation does not require kinase activity. Journal of Neurochemistry. PMID 26212614 DOI: 10.1111/jnc.13263  1
2014 Coultrap SJ, Zaegel V, Bayer KU. CaMKII isoforms differ in their specific requirements for regulation by nitric oxide. Febs Letters. 588: 4672-6. PMID 25447522 DOI: 10.1016/j.febslet.2014.10.039  1
2014 Tao-Cheng JH, Yang Y, Bayer KU, Reese TS, Dosemeci A. NMDA-induced accumulation of Shank at the postsynaptic density is mediated by CaMKII. Biochemical and Biophysical Research Communications. 450: 808-11. PMID 24952157 DOI: 10.1016/j.bbrc.2014.06.049  1
2014 Thein S, Pham A, Bayer KU, Tao-Cheng JH, Dosemeci A. IKK regulates the deubiquitinase CYLD at the postsynaptic density. Biochemical and Biophysical Research Communications. 450: 550-4. PMID 24928390 DOI: 10.1016/j.bbrc.2014.06.019  1
2014 Coultrap SJ, Bayer KU. Nitric oxide induces Ca2+-independent activity of the Ca2+/calmodulin-dependent protein kinase II (CaMKII). The Journal of Biological Chemistry. 289: 19458-65. PMID 24855644 DOI: 10.1074/jbc.M114.558254  1
2014 Barcomb K, Buard I, Coultrap SJ, Kulbe JR, O'Leary H, Benke TA, Bayer KU. Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 3810-9. PMID 24843070 DOI: 10.1096/fj.14-250407  1
2014 Goodell DJ, Eliseeva TA, Coultrap SJ, Bayer KU. CaMKII binding to GluN2B is differentially affected by macromolecular crowding reagents. Plos One. 9: e96522. PMID 24796865 DOI: 10.1371/journal.pone.0096522  1
2014 Bernard PB, Castano AM, Bayer KU, Benke TA. Necessary, but not sufficient: insights into the mechanisms of mGluR mediated long-term depression from a rat model of early life seizures. Neuropharmacology. 84: 1-12. PMID 24780380 DOI: 10.1016/j.neuropharm.2014.04.011  1
2014 Turecek J, Yuen GS, Han VZ, Zeng XH, Bayer KU, Welsh JP. NMDA receptor activation strengthens weak electrical coupling in mammalian brain. Neuron. 81: 1375-88. PMID 24656255 DOI: 10.1016/j.neuron.2014.01.024  1
2014 Coultrap SJ, Freund RK, O'Leary H, Sanderson JL, Roche KW, Dell'Acqua ML, Bayer KU. Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection. Cell Reports. 6: 431-7. PMID 24485660 DOI: 10.1016/j.celrep.2014.01.005  1
2014 Liu X, Liu Y, Zhong P, Wilkinson B, Qi J, Olsen CM, Bayer KU, Liu QS. CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 989-99. PMID 24154664 DOI: 10.1038/npp.2013.299  1
2013 Barcomb K, Coultrap SJ, Bayer KU. Enzymatic activity of CaMKII is not required for its interaction with the glutamate receptor subunit GluN2B. Molecular Pharmacology. 84: 834-43. PMID 24056996 DOI: 10.1124/mol.113.089045  1
2013 Yang Y, Tao-Cheng JH, Bayer KU, Reese TS, Dosemeci A. Camkii-mediated phosphorylation regulates distributions of Syngap-α1 and -α2 at the postsynaptic density. Plos One. 8: e71795. PMID 23967245 DOI: 10.1371/journal.pone.0071795  1
2013 Tao-Cheng JH, Yang Y, Bayer KU, Reese TS, Dosemeci A. Effects of CaMKII inhibitor tatCN21 on activity-dependent redistribution of CaMKII in hippocampal neurons. Neuroscience. 244: 188-96. PMID 23583761 DOI: 10.1016/j.neuroscience.2013.03.063  1
2013 Loweth JA, Li D, Cortright JJ, Wilke G, Jeyifous O, Neve RL, Bayer KU, Vezina P. Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 1411-6. PMID 23345217 DOI: 10.1523/JNEUROSCI.4386-13.2013  1
2012 Boguslavsky S, Chiu T, Foley KP, Osorio-Fuentealba C, Antonescu CN, Bayer KU, Bilan PJ, Klip A. Myo1c binding to submembrane actin mediates insulin-induced tethering of GLUT4 vesicles. Molecular Biology of the Cell. 23: 4065-78. PMID 22918957 DOI: 10.1091/mbc.E12-04-0263  1
2012 Coultrap SJ, Bayer KU. CaMKII regulation in information processing and storage. Trends in Neurosciences. 35: 607-18. PMID 22717267 DOI: 10.1016/j.tins.2012.05.003  1
2012 Coultrap SJ, Barcomb K, Bayer KU. A significant but rather mild contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity. Plos One. 7: e37176. PMID 22615928 DOI: 10.1371/journal.pone.0037176  1
2011 Coultrap SJ, Bayer KU. Improving a natural CaMKII inhibitor by random and rational design. Plos One. 6: e25245. PMID 21984908 DOI: 10.1371/journal.pone.0025245  1
2011 O'Leary H, Liu WH, Rorabaugh JM, Coultrap SJ, Bayer KU. Nucleotides and phosphorylation bi-directionally modulate Ca2+/calmodulin-dependent protein kinase II (CaMKII) binding to the N-methyl-D-aspartate (NMDA) receptor subunit GluN2B. The Journal of Biological Chemistry. 286: 31272-81. PMID 21768120 DOI: 10.1074/jbc.M111.233668  1
2011 Sanhueza M, Fernandez-Villalobos G, Stein IS, Kasumova G, Zhang P, Bayer KU, Otmakhov N, Hell JW, Lisman J. Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 9170-8. PMID 21697368 DOI: 10.1523/JNEUROSCI.1250-11.2011  0.48
2011 Coultrap SJ, Vest RS, Ashpole NM, Hudmon A, Bayer KU. CaMKII in cerebral ischemia. Acta Pharmacologica Sinica. 32: 861-72. PMID 21685929 DOI: 10.1038/aps.2011.68  1
2010 Marsden KC, Shemesh A, Bayer KU, Carroll RC. Selective translocation of Ca2+/calmodulin protein kinase IIalpha (CaMKIIalpha) to inhibitory synapses. Proceedings of the National Academy of Sciences of the United States of America. 107: 20559-64. PMID 21059908 DOI: 10.1073/pnas.1010346107  1
2010 Buard I, Coultrap SJ, Freund RK, Lee YS, Dell'Acqua ML, Silva AJ, Bayer KU. CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8214-20. PMID 20554872 DOI: 10.1523/JNEUROSCI.1469-10.2010  1
2010 Vest RS, O'Leary H, Coultrap SJ, Kindy MS, Bayer KU. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. The Journal of Biological Chemistry. 285: 20675-82. PMID 20424167 DOI: 10.1074/jbc.M109.088617  1
2010 Cipolletta E, Monaco S, Maione AS, Vitiello L, Campiglia P, Pastore L, Franchini C, Novellino E, Limongelli V, Bayer KU, Means AR, Rossi G, Trimarco B, Iaccarino G, Illario M. Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology. 151: 2747-59. PMID 20392834 DOI: 10.1210/en.2009-1248  1
2010 Coultrap SJ, Buard I, Kulbe JR, Dell'Acqua ML, Bayer KU. CaMKII autonomy is substrate-dependent and further stimulated by Ca2+/calmodulin. The Journal of Biological Chemistry. 285: 17930-7. PMID 20353941 DOI: 10.1074/jbc.M109.069351  1
2009 Vest RS, O'Leary H, Bayer KU. Differential regulation by ATP versus ADP further links CaMKII aggregation to ischemic conditions. Febs Letters. 583: 3577-81. PMID 19840793 DOI: 10.1016/j.febslet.2009.10.028  1
2007 Vest RS, Davies KD, O'Leary H, Port JD, Bayer KU. Dual mechanism of a natural CaMKII inhibitor. Molecular Biology of the Cell. 18: 5024-33. PMID 17942605 DOI: 10.1091/mbc.E07-02-0185  1
2007 Rokhlin OW, Taghiyev AF, Bayer KU, Bumcrot D, Koteliansk VE, Glover RA, Cohen MB. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biology & Therapy. 6: 732-42. PMID 17387273  1
2006 O'Leary H, Lasda E, Bayer KU. CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing. Molecular Biology of the Cell. 17: 4656-65. PMID 16928958 DOI: 10.1091/mbc.E06-03-0252  1
2006 O'Leary H, Sui X, Lin PJ, Volpe P, Bayer KU. Nuclear targeting of the CaMKII anchoring protein alphaKAP is regulated by alternative splicing and protein kinases. Brain Research. 1086: 17-26. PMID 16616897 DOI: 10.1016/j.brainres.2006.02.120  1
2006 Bayer KU, LeBel E, McDonald GL, O'Leary H, Schulman H, De Koninck P. Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1164-74. PMID 16436603 DOI: 10.1523/JNEUROSCI.3116-05.2006  1
2003 Illario M, Cavallo AL, Bayer KU, Di Matola T, Fenzi G, Rossi G, Vitale M. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. The Journal of Biological Chemistry. 278: 45101-8. PMID 12954639 DOI: 10.1074/jbc.M305355200  1
2003 Fink CC, Bayer KU, Myers JW, Ferrell JE, Schulman H, Meyer T. Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron. 39: 283-97. PMID 12873385 DOI: 10.1016/S0896-6273(03)00428-8  1
2003 Nori A, Lin PJ, Cassetti A, Villa A, Bayer KU, Volpe P. Targeting of alpha-kinase-anchoring protein (alpha KAP) to sarcoplasmic reticulum and nuclei of skeletal muscle. The Biochemical Journal. 370: 873-80. PMID 12470297 DOI: 10.1042/BJ20021624  1
2002 Leonard AS, Bayer KU, Merrill MA, Lim IA, Shea MA, Schulman H, Hell JW. Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-D-aspartate receptors by calcium/calmodulin and alpha-actinin. The Journal of Biological Chemistry. 277: 48441-8. PMID 12379661 DOI: 10.1074/jbc.M205164200  1
2002 Bayer KU, De Koninck P, Schulman H. Alternative splicing modulates the frequency-dependent response of CaMKII to Ca(2+) oscillations. The Embo Journal. 21: 3590-7. PMID 12110572 DOI: 10.1093/emboj/cdf360  1
2001 Bayer KU, Schulman H. Regulation of signal transduction by protein targeting: the case for CaMKII. Biochemical and Biophysical Research Communications. 289: 917-23. PMID 11741277 DOI: 10.1006/bbrc.2001.6063  1
2001 Bayer KU, De Koninck P, Leonard AS, Hell JW, Schulman H. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature. 411: 801-5. PMID 11459059 DOI: 10.1038/35081080  1
1999 Bayer KU, Löhler J, Schulman H, Harbers K. Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta-CaM kinase II are the early isoforms and most abundant in the developing nervous system. Brain Research. Molecular Brain Research. 70: 147-54. PMID 10381553 DOI: 10.1016/S0169-328X(99)00131-X  1
1998 Bayer KU, Harbers K, Schulman H. alphaKAP is an anchoring protein for a novel CaM kinase II isoform in skeletal muscle. The Embo Journal. 17: 5598-605. PMID 9755160 DOI: 10.1093/emboj/17.19.5598  1
1996 Bayer KU, Löhler J, Harbers K. An alternative, nonkinase product of the brain-specifically expressed Ca2+/calmodulin-dependent kinase II alpha isoform gene in skeletal muscle. Molecular and Cellular Biology. 16: 29-36. PMID 8524307  1
1994 Hamann L, Bayer KU, Jensen K, Harbers K. Interaction of several related GC-box- and GT-box-binding proteins with the intronic enhancer is required for differential expression of the gb110 gene in embryonal carcinoma cells. Molecular and Cellular Biology. 14: 5786-93. PMID 8065313  1
Show low-probability matches.